RSNA to release three new journals in 2019

Published on:

Come 2019, RSNA will begin publishing three new subspecialty online journals, according to a recent press release. RSNA members will receive full access to the three new digital journals that will be focused solely on cancer imaging, cardiothoracic imaging and machine learning/ artificial intelligence. 

"The new journals will complement Radiology and RadioGraphics and provide a way to keep practicing physicians and imaging researchers up-to-date on the best emerging science in each subspecialty," according to the RSNA press release.   

Specifically, the cancer imaging journal will provide research and topical reviews on cancer screening, differential diagnosis and imaging treatment planning. The cardiothoracic imaging journal will promote research advances and technical developments for cardiothoracic imaging and the machine learning/artificial intelligence journal will shed light on emerging technologies and applications across all disciplines of health imaging.  

According to RSNA, submissions for each new journal will be accepted starting in 2018; the search for editors for the journals will begin in November 2017.  

For more information about applying for an editor's position and about the new journals, see the full RSNA press release here.  

 

Related Content

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
Building a successful CCTA program: Physicians and healthcare executives to share advice
How AI and CCTA help heart teams plan ahead before PCI
Cardiologists recommend complete revascularization, intravascular imaging in new ACS guidelines
Why cardiac CT adoption remains low among primary care providers
Detecting coronary inflammation on CT imaging could reshape preventive cardiology

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.